| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/17/2012 | CA2385456C 9-(piperazinylalkyl) carbazoles as bax-modulators |
| 01/17/2012 | CA2148712C Peripheralization of hematopoietic stem cells |
| 01/12/2012 | WO2012006321A2 Novel antibacterial compounds, methods of making them, and uses thereof |
| 01/12/2012 | WO2012005379A1 Transformant obtained by introducing gm1 gene and crmp2 gene |
| 01/12/2012 | WO2012005343A1 Substituted pyridine compound |
| 01/12/2012 | WO2012005313A1 Cyclic peptide compound or pharmacologically acceptable salt thereof and method for producing same |
| 01/12/2012 | WO2012005299A1 Ros tyrosine kinase inhibitor |
| 01/12/2012 | WO2012005240A1 Bifidobacterium having activity of reducing amount of intestinal putrefacted substance |
| 01/12/2012 | WO2012005229A1 N-hydroxyformamide derivative and pharmaceutical containing same |
| 01/12/2012 | WO2012005227A1 Tetrahydrocarboline derivative |
| 01/12/2012 | WO2012004900A1 Thienopyrimidine compounds |
| 01/12/2012 | WO2012004330A1 Nos-inhibitor l-nil for use in chronic pulmonary diseases |
| 01/12/2012 | WO2012004234A1 Sn-2-monoacylglycerols and lipid malabsorption |
| 01/12/2012 | WO2011129427A9 Diagnostic agent and therapeutic agent for cancer |
| 01/12/2012 | WO2011119929A3 Composition for enhancing athletic performance |
| 01/12/2012 | WO2011112002A3 Composition for treating, preventing or relieving macular degeneration, containing vaccinium uliginosum extract or vaccinium uliginosum fractions as active ingredient |
| 01/12/2012 | US20120010295 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 01/12/2012 | US20120010276 Screening and therapy for lymphatic disorders involving the flt4 receptor tyrosine kinase (vegfr-3) |
| 01/12/2012 | US20120010271 Single-stranded nucleic acid molecule for controlling gene expression |
| 01/12/2012 | US20120010263 Acetylene derivatives having mglur 5 antagonistic activity |
| 01/12/2012 | US20120010194 11-Beta-Hydroxysteroid Dehydrogenase Type 1 Active Compounds |
| 01/12/2012 | US20120010163 Novel antibacterial compounds, methods of making them, and uses thereof |
| 01/12/2012 | US20120010161 Novel azapeptide or azapeptidomimetic compounds inhibiting bcrp and/or p-gp |
| 01/12/2012 | US20120010144 Peg-albumin composition having at least one protected thiol region as a platform for medications |
| 01/12/2012 | US20120010126 Recombinant surfactant protein d compositions and methods of use thereof |
| 01/12/2012 | US20120009648 DNA polymerase lambda and uses thereof |
| 01/12/2012 | US20120009230 Malleable implants containing demineralized bone matrix |
| 01/12/2012 | US20120009211 Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins |
| 01/12/2012 | US20120009206 Novel double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biologic activity |
| 01/12/2012 | US20120009152 Nitric oxide donors for treatment of disease and injury |
| 01/12/2012 | US20120009139 Methods and Compositions for Promoting Organ Development |
| 01/12/2012 | CA2804924A1 Substituted pyridine compound |
| 01/12/2012 | CA2804918A1 N-hydroxyformamide derivative and medicament containing same |
| 01/12/2012 | CA2802216A1 Tetrahydrocarboline derivative |
| 01/11/2012 | EP2405015A2 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 01/11/2012 | EP2404908A1 Process for producing phenyl-substituted heterocyclic derivative through coupling using transition metal catalyst |
| 01/11/2012 | EP2404902A1 Piperidine and pyrrolidine derivatives having npy y5 receptor antagonism |
| 01/11/2012 | EP2404896A1 Cyclohexane derivative having npy y5 receptor antagonism |
| 01/11/2012 | EP2404895A1 Calixarene-based peptide conformation mimetics, methods of use, and methods of making |
| 01/11/2012 | EP2404617A1 Frequency physical carrier for diagnostics, medical therapy and human, zootechnical and agronomic enhancement |
| 01/11/2012 | EP2404610A1 Prophylactic or therapeutic agent for rheumatoid arthritis or rheumatoid arthritis-related diseases |
| 01/11/2012 | EP2404608A1 Combination use of cholestanol derivative |
| 01/11/2012 | EP2404606A1 Ophthalmic compositions comprising a prostaglandin and a viscosity agent |
| 01/11/2012 | EP2404603A1 Novel trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds for the treatment of CSBP/p38 kinase mediated diseases |
| 01/11/2012 | EP2404597A1 NOS-inhibitor L-NIL for use in chronic lung diseases |
| 01/11/2012 | EP2404596A1 Kit for Cancer Treatment and Pharmaceutical Composition for Cancer Treatment |
| 01/11/2012 | EP2403491A2 Alkylglycerols and alkoxyglycerols for increasing endogenous plasmalogen levels in mammals |
| 01/11/2012 | EP1609798A9 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 01/11/2012 | EP1566380B1 Isoquinoline compounds and medicinal use thereof |
| 01/11/2012 | EP1511845B1 Immunostimulatory oligonucleotides and uses thereof |
| 01/11/2012 | EP1381377B1 A composition including a ginkgolide and apocynin which interferes with the arachidonic acid cascade |
| 01/11/2012 | CN102317282A Hetero ring derivative |
| 01/11/2012 | CN102317280A Oxyindole derivatives with motilin receptor agonistic activity |
| 01/11/2012 | CN102316900A Aniline derivative having anti-rna viral activity |
| 01/11/2012 | CN102316899A Use of an immunoglobulin G (IgG) concentrate depleted of anti-A and anti-B antibodies for treating neonatal jaundice caused by maternal-foetal incompatibility with respect to the ABO system |
| 01/11/2012 | CN102316886A Skin aging-inhibiting peptide |
| 01/11/2012 | CN102316873A Compounds and methods for enhancing erythropoiesis |
| 01/11/2012 | CN102311396A Pyrazine derivative and preparation method as well as application thereof to pharmacy |
| 01/11/2012 | CN102309730A Traditional Chinese medicine powder for treating belching |
| 01/11/2012 | CN102309673A Traditional Chinese medicine pill for treating retardation in speech |
| 01/11/2012 | CN102309564A Anti-stress drug used for aquatic livestock and its preparation method |
| 01/11/2012 | CN102309562A Preparation method of taste-masked suspension granules of Gegenqinlian decoction |
| 01/11/2012 | CN102309550A Traditional Chinese medicinal aerosol for preventing and treating summer humidity disease and preparation method thereof |
| 01/11/2012 | CN102309533A Preparation method of total flavones of artemisia anomalas |
| 01/11/2012 | CN102309527A Drug for controlling death stealing of Penaeus vannamei Boone and preparation method thereof |
| 01/11/2012 | CN102309494A Medicinal application of pristimerin as inflammatory cytokine inhibitor |
| 01/11/2012 | CN102085285B Traditional Chinese medicine combined prescription for treating paraplegia and bone fracture sequelae |
| 01/11/2012 | CN102078336B Traditional Chinese medicine composition with function of improving microcirculation and preparation method and application thereof |
| 01/11/2012 | CN101675922B Parakeratosis inhibitor, pore-shrinking agent and skin preparation for external use |
| 01/11/2012 | CN101602767B Preparation method of galanthamine |
| 01/11/2012 | CN101596265B Traditional Chinese medicine compound preparation for enhancing body fatigue resistance |
| 01/11/2012 | CN101570559B Method for preparing 5-aza-2'-deoxycytidine and its intermediates |
| 01/11/2012 | CN101491628B Lycium-rehmannia preparation preparation method |
| 01/11/2012 | CN101198354B Preventive or remedy for glaucoma |
| 01/10/2012 | US8093403 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same |
| 01/10/2012 | US8093286 Methods for treatment with bucindolol based on genetic targeting |
| 01/10/2012 | US8093278 Substituted indoles |
| 01/10/2012 | US8093217 For sensitizing multi-drug resistant cancer or radiation resistant cancer cells to chemotherapeutic agents |
| 01/10/2012 | US8092809 Pseudomonas exotoxin A-like chimeric immunogens |
| 01/10/2012 | CA2503719C Pharmaceutical solutions comprising a modafinil compound and their use for the manufacture of a medicament for treating different diseases |
| 01/10/2012 | CA2496797C Therapeutic agent for glaucoma comprising rho kinase inhibitor and prostaglandin |
| 01/10/2012 | CA2486183C Protein kinase inhibitors |
| 01/10/2012 | CA2479666C (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
| 01/10/2012 | CA2464334C Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
| 01/10/2012 | CA2444692C Use of neuronal sodium channel antagonists for the control of ectoparasites in homeothermic animals |
| 01/10/2012 | CA2440605C Methods for treating stress disorders using glucocorticoid receptor-specific antagonists |
| 01/10/2012 | CA2404488C Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis |
| 01/05/2012 | WO2012003349A2 Dissolvable fibrous web structure article comprising active agents |
| 01/05/2012 | WO2012002582A1 Partial region polypeptide of reic/dkk-3 protein |
| 01/05/2012 | WO2012002577A1 Novel nicotinamide derivatives or salts thereof |
| 01/05/2012 | WO2012002539A1 Novel noncrystalline bosentan and process for preparation thereof |
| 01/05/2012 | WO2012002536A1 Vegf production promoter |
| 01/05/2012 | WO2012002527A1 HETEROCYCLIC COMPOUND, AND p27 KIP1 DEGRADATION INHIBITOR |
| 01/05/2012 | WO2012002522A1 Therapeutic agent for indications for haloperidol, and beverage or food |
| 01/05/2012 | WO2012002502A1 Dihydropyrimidinone derivative and pharmaceutical use thereof |
| 01/05/2012 | WO2012001941A1 Prophylactic or ameliorating agent for genetic diseases |
| 01/05/2012 | WO2012001170A1 Telomerase reverse transcriptase for protection against ageing |
| 01/05/2012 | WO2011093672A3 Bicyclic heteroaryl derivatives having inhibitory activity for protein kinase |
| 01/05/2012 | WO2002092832A9 Human and non-human primate homologues of nkd protein, nucleic acid sequences encoding, and uses thereof |
| 01/05/2012 | US20120004319 Process for producing carotenoid |